Prognostic Value of Rho GTPases and Rho Guanine Nucleotide Dissociation Inhibitors in Human Breast Cancers

Clinical Cancer Research

Volumn 9, Issue 17, 2003, Pages 6432-6440

  Jiang, Wen G ^a   Watkins, Gareth ^a   Lane, Jane ^a   Cunnick, Giles H ^a   Douglas Jones, Anthony ^a   Mokbel, Kefah ^b   Mansel, Robert E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN 6; RHO GUANINE NUCLEOTIDE BINDING PROTEIN 7; RHO GUANINE NUCLEOTIDE BINDING PROTEIN 8; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR BETA; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR GAMMA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC GUANINE NUCLEOTIDE BINDING PROTEIN; RHOG GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER SURVIVAL; FOLLOW UP; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE-FREE SURVIVAL; DNA, COMPLEMENTARY; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; NEOPLASM METASTASIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS; RNA; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 0347594125     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Santos, E., Tronick, S. R., Aarronson, S. A., Pulciani, S., and Narbacid, M. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature (Lond.), 298: 343-347, 1982.
2. Hall, A., Marshall, C. J., Spurr, N. K., and Weiss, R. A. Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. Nature (Lond.), 303: 396-400, 1983.
3. van Aelst, L., and D'Souxza-Schorey, C. Rho GTPases and signaling networks. Genes Dev., 11: 2295-2322, 1997.
4. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., Gocayne, J. D., Amanatides, P., et al. The sequence of the human genome. Science (Wash. DC), 291: 1304-1351, 2001.
5. Jaffe, A. B., and Hall, A. Rho GTPases in transformation and metastasis. Adv. Cancer Res., 84: 57-80, 2002.
6. Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., and Hall, A. The small GTP-binding protein rac regulates growth factor induced membrane ruffling. Cell, 70: 401-410, 1992.
7. Nobes, C. D., and Hall, A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell, 81: 53-62, 1995.
8. Takaishi, K., Sasaki, T., Kotani, H., Nishioka, H., and Takai, Y. Regulation of cell-cell adhesion by rac and rho small g proteins in MDCK cells. J. Cell Biol., 137: 1421-1431, 1997.
9. Jiang, W. G., Hiscox, S., Singhrao, S. K., Puntis, M. C. A., Nakamura, T., and Hallett, M. B. Inhibition of HGF/SF induced membrane ruffling and cell motility by transient elevation of cytosolic free calcium. Exp. Cell Res., 200: 424-433, 1995.
10. Kozma, R., Ahmed, S., Best, A., and Lim, L. The Ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. Mol. Cell. Biol., 15: 1942-1952, 1995.
11. Sander, E. E., van Delft, S., ten Klooster, J. P., Reid, T., van der Kammen, R. A., Michiels, F., and Collard, J. G. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol., 147: 1009-1022, 1999.
12. Yoshioka, K., Nakamori, S., and Itoh, K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res., 59: 2004-2010, 1999.
13. Liberto, M., Cobrinik, D., and Minden, A. Rho regulates p21 (CIP1) cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene, 21: 1590-1599, 2002.
14. Ghosh, P. M., Bedolla, R., Mikhailova, M., and Kreisberg, S. I. RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase C ζ. Cancer Res., 62: 2630-2636, 2002.
15. Bishop, A. L., and Hall, A. Rho GTPases and their effector proteins. Biochem. J., 2000, 348: 241-255, 2002.
16. Hall, A. Rho GTPases and the actin cytoskeleton. Science (Wash. DC), 279: 509-514, 1998.
17. van Golen, K. L., Wu, Z. F., Qiao, X. T., Bao, L. W., and Merajver, S. D. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res., 60: 5832-5838, 2000.
18. van Golen, K. L., Davies, S., Wu, Z. F., Wang, Y. F., Bucana, C. D., Root, H., Chandrasekharappa, S., Strawderman, M., Ethier, S. P., and Merajver, S. D. A. novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin. Cancer Res., 5: 2511-2519, 1999.
19. Genda, T., Sakamoto, M., Ichida, T., Asakura, H., Kojiro, M., Narumiya, S., and Hirohashi, S. Cell motility mediated by Rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology, 30: 1027-1036, 1999.
20. Kamai, T., Arai, K., Sumi, S., Tsujii, T., Honda, M., Yamanishi, T., and Yoshida, K. I. The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumour. Br. J. Urol. Int., 89: 449-453, 2002.
21. Suwa, H., Ohshio, G., Imamura, T., Watanabe, G., Arii, S., Imamura, M., Narumiya, S., Hiai, H., and Fukumoto, M. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br. J. Cancer, 177: 147-152, 1998.
22. Kleer, C. G., van Golen, K. L., Zhang, Y. H., Wu, Z. F., Rubin, M. A., and Merajver, S. D. Characterization of RhoC expression in benign and malignant breast disease - a potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol., 160: 579-584, 2002.
23. Clark, E. A., Golub, T. R., Lander, E. S., and Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature (Lond.), 406: 532-535, 2000.
24. Bouzahzah, B., Albanese, C., Ahmed, F., Pixley, F., Lisanti, M. P., Segall, J. D., Condeelis, J., Joyce, D., Minden, A., Der, C. J., Chan, A., Symons, M., and Pestell, R. G. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol. Medicine, 7: 816-830, 2001.
25. Jiang, W. G., Douglas-Jones, A., and Mansel, R. E. Level of expression of lipoxygenase-5, 12, and 15 and cyclooxygenase in human breast cancer. Prostaglaindins Leukot. Essent. Fatty Acids, 69: 275-281, 2003.
26. Jiang, W. G., Douglas-Jones, A., and Mansel, R. E. Level of expression of PPAR-γ and its co-activator (PPAR-GCA) in human breast cancer. Int. J. Cancer, 106: 752-757, 2003.
27. Lin, Y., Martin, T. A., Mansel, R. E., and Jiang, W. G. Biphasic effects of 17-β-oestradiol on expression of occludin and transendothelial resistance (TER) and paracellular permeability in human vascular endothelial cells. J. Cell. Physiol., 196: 362-369, 2003.
28. Somlyo, A. V., Bradshaw, D., Ramos, S., Murphy, C., Myers, C. E., and Somlyo, A. P. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem. Biophys. Res. Commun., 269: 652-659, 2000.
29. Seraj, M. J., Harding, M. A., Gildea, J. J., Welch, D. R., and Theodorescu, D. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin. Exp. Metastasis, 18: 519-525, 2001.
30. Tapper, J., Kettunen, E., El-Rifai, W., Seppala, M., Andersson, L. C., and Knuutila, S. Changes in gene expression during progression of ovarian carcinoma. Cancer Genet. Cytogenet., 128: 1-6, 2001.
31. Su, L. F., Knoblauch, R., and Garabedian, M. J. Rho GTPases as modulators of the estrogen receptor transcriptional response. J. Biol. Chem., 276: 3231-3237, 2001.
32. van Golen, K. L., Wu, Z. F., Qiao, X. T., Bao, L. W., and Merajver, S. D. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia, 2: 418-425, 2000.
33. Okamoto, I., Kawano, Y., Matsumoto, M., Suga, M., Kaibuchi, K., Ando, M., and Saya, H. Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J. Biol. Chem., 274: 25525-25534, 1999.
34. Tokman, M. G., Porter, R. A., and Williams, C. L. Regulation of cadherin-mediated adhesion by the small GTP-binding protein Rho in small cell lung carcinoma cells. Cancer Res., 57: 1785-1793, 1997.
35. Ried, S., Jager, C., Jeffers, M., Vande Woude, G. F., Graeff, H., Schmitt, M., and Lengyel, E. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor scatter factor. J. Biol. Chem., 274: 16377-16386, 1999.
36. Ghosh, P. M., Ghosh-Choudhury, N., Moyer, M. L., Mott, G. E., Thomas, C. A., Foster, B. A., Greenberg, N. M., and Kreisberg, J. I. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line. Oncogene, 18: 4120-4130, 1999.
37. Chen, Z., Sun, J. Z., Pradines, A., Favre, G., Adnane, J., and Sebti, S. M. Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice. J. Biol. Chem., 275: 17974-17978, 2000.
38. Murga, C., Zohar, M., Teramoto, H., and Gutkind, J. S. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-κB. Oncogene, 21: 207-216, 2002.
39. Moscow, J. A., He, R., Gnarra, J. R., Knutsen, T., Weng, Y. K., Zhao, W. P., Whangpeng, J., Linehan, W. M., and Cowan, K. H. Examination of human tumors for rhoa mutations. Oncogene, 9: 189-194, 1995.